SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Elevance Health, Inc. – ‘10-K’ for 12/31/22 – ‘EX-23’

On:  Wednesday, 2/15/23, at 4:44pm ET   ·   For:  12/31/22   ·   Accession #:  1156039-23-7   ·   File #:  1-16751

Previous ‘10-K’:  ‘10-K’ on 2/16/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 2/21/24 for 12/31/23   ·   32 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/15/23  Elevance Health, Inc.             10-K       12/31/22  152:27M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   5.36M 
 2: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     57K 
 3: EX-10.1     Material Contract                                   HTML    312K 
 4: EX-10.11    Material Contract                                   HTML    855K 
 5: EX-10.12    Material Contract                                   HTML    795K 
 6: EX-21       Subsidiaries List                                   HTML    185K 
 7: EX-23       Consent of Expert or Counsel                        HTML     41K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     45K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     45K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     42K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     42K 
17: R1          Document And Entity Information                     HTML    104K 
18: R2          Audit Information                                   HTML     46K 
19: R3          Consolidated Balance Sheets                         HTML    177K 
20: R4          Consolidated Balance Sheets (Parenthetical)         HTML     65K 
21: R5          Consolidated Statements of Income                   HTML    134K 
22: R6          Consolidated Statements of Comprehensive Income     HTML     82K 
23: R7          Consolidated Statements of Cash Flows               HTML    151K 
24: R8          Consolidated Statements of Changes in Equity        HTML    152K 
25: R9          Organization                                        HTML     49K 
26: R10         Basis Of Presentation And Significant Accounting    HTML    109K 
                Policies                                                         
27: R11         Business Acquisitions                               HTML     71K 
28: R12         Business Optimization Initiatives                   HTML     62K 
29: R13         Investments                                         HTML    218K 
30: R14         Derivative Financial Instruments                    HTML    137K 
31: R15         Fair Value                                          HTML    275K 
32: R16         Income Taxes                                        HTML    122K 
33: R17         Property And Equipment                              HTML     54K 
34: R18         Goodwill And Other Intangible Assets                HTML     95K 
35: R19         Retirement Benefits                                 HTML    303K 
36: R20         Medical Claims Payable                              HTML    228K 
37: R21         Debt                                                HTML    114K 
38: R22         Commitments And Contingencies                       HTML     74K 
39: R23         Capital Stock                                       HTML    116K 
40: R24         Accumulated Other Comprehensive Loss                HTML     82K 
41: R25         Reinsurance                                         HTML     76K 
42: R26         Leases                                              HTML     77K 
43: R27         Earnings Per Share                                  HTML     50K 
44: R28         Segment Information                                 HTML    141K 
45: R29         Related Party Transactions                          HTML     44K 
46: R30         Statutory Information                               HTML     46K 
47: R31         Schedule II-Condensed Financial Information Of      HTML    167K 
                Registrant                                                       
48: R32         Basis Of Presentation And Significant Accounting    HTML    163K 
                Policies (Policy)                                                
49: R33         Business Acquisitions (Tables)                      HTML     66K 
50: R34         Business Optimization Initiatives (Tables)          HTML     58K 
51: R35         Investments (Tables)                                HTML    219K 
52: R36         Derivative Financial Instruments (Tables)           HTML    144K 
53: R37         Fair Value (Tables)                                 HTML    257K 
54: R38         Income Taxes (Tables)                               HTML    121K 
55: R39         Property And Equipment (Tables)                     HTML     52K 
56: R40         Goodwill And Other Intangible Assets (Tables)       HTML     97K 
57: R41         Retirement Benefits (Tables)                        HTML    310K 
58: R42         Medical Claims Payable (Tables)                     HTML    234K 
59: R43         Debt (Tables)                                       HTML     89K 
60: R44         Capital Stock (Tables)                              HTML    111K 
61: R45         Accumulated Other Comprehensive Loss (Tables)       HTML     82K 
62: R46         Reinsurance (Tables)                                HTML     78K 
63: R47         Leases (Tables)                                     HTML     78K 
64: R48         Earnings Per Share (Tables)                         HTML     49K 
65: R49         Segment Information (Tables)                        HTML    137K 
66: R50         Organization (Details)                              HTML     45K 
67: R51         Basis Of Presentation And Significant Accounting    HTML    109K 
                Policies (Details)                                               
68: R52         Business Acquisitions (Acquired tangible assets     HTML     59K 
                and liabilities) (Details)                                       
69: R53         Business Acquisitions (Intangible Assets Acquired)  HTML     57K 
                (Details)                                                        
70: R54         Business Acquisitions (Narrative) (Details)         HTML     70K 
71: R55         Business Optimization Initiatives (Employee         HTML     60K 
                Termination Costs) (Details)                                     
72: R56         Business Optimization Initiatives (Narrative)       HTML     69K 
                (Details)                                                        
73: R57         Investments (Current And Long-Term Investments,     HTML     85K 
                Available-For-Sale) (Details)                                    
74: R58         Investments (Aggregate Fair Value And Gross         HTML     93K 
                Unrealized Loss Of Fixed Maturity Securities In An               
                Unrealized Loss Position) (Details)                              
75: R59         Investments (Amortized Cost And Fair Value Of       HTML     75K 
                Fixed Maturity Securities, By Contractual                        
                Maturity) (Details)                                              
76: R60         Investments (Current Equity Securities) (Details)   HTML     48K 
77: R61         Investments (Major Categories Of Net Investment     HTML     56K 
                Income) (Details)                                                
78: R62         Investments (Net Gains/Losses On Investments)       HTML     70K 
                (Details)                                                        
79: R63         Investments (Narrative) (Details)                   HTML     75K 
80: R64         Derivative Financial Instruments (Notional          HTML     87K 
                Amounts, Balance Sheet Location And Estimated Fair               
                Values Of Derivative Financial Instruments)                      
                (Details)                                                        
81: R65         Derivative Financial Instruments (Summary Of        HTML     72K 
                Outstanding Fair Value Hedges) (Details)                         
82: R66         Derivative Financial Instruments Derivative         HTML     45K 
                Financial Instruments (Fair Value Hedges,                        
                Financial Position) (Details)                                    
83: R67         Derivative Financial Instruments (Effect Of         HTML     58K 
                Non-Hedging Derivatives On Income Statement And                  
                Included In Net Gains (Losses) On Investments)                   
                (Details)                                                        
84: R68         Derivative Financial Instruments (Narrative)        HTML     53K 
                (Details)                                                        
85: R69         Fair Value (Fair Value Measurements By Level For    HTML    144K 
                Assets Measured At Fair Value On A Recurring                     
                Basis) (Details)                                                 
86: R70         Fair Value (Reconciliation Of The Beginning And     HTML     90K 
                Ending Balances Of Assets Measured At Fair Value                 
                On A Recurring Basis Using Level III Inputs)                     
                (Details)                                                        
87: R71         Fair Value (Carrying and Fair Value By Level of     HTML     73K 
                Financial Instruments Not Recorded At Fair Value                 
                On Consolidated Balance Sheet) (Details)                         
88: R72         Income Taxes(Components Of Deferred Income Taxes)   HTML     91K 
                (Details)                                                        
89: R73         Income Taxes (Components Of Provision For Income    HTML     59K 
                Taxes) (Details)                                                 
90: R74         Income Taxes (Reconciliation Of Income Tax Expense  HTML     75K 
                Computed At The Statutory Federal Income Tax Rate)               
                (Details)                                                        
91: R75         Income Taxes (Change In The Carrying Amount Of      HTML     50K 
                Gross Unrecognized Tax Benefits From Uncertain Tax               
                Positions) (Details)                                             
92: R76         Income Taxes (Narrative) (Details)                  HTML    101K 
93: R77         Property And Equipment (Summary Of Property And     HTML     60K 
                Equipment) (Details)                                             
94: R78         Property And Equipment (Narrative) (Details)        HTML     52K 
95: R79         Goodwill And Other Intangible Assets (Summary Of    HTML     62K 
                The Change In The Carrying Amount Of Goodwill By                 
                Reportable Segment) (Details)                                    
96: R80         Goodwill And Other Intangible Assets (Components    HTML     70K 
                Of Other Intangible Assets) (Details)                            
97: R81         Goodwill And Other Intangible Assets (Narrative)    HTML     56K 
                (Details)                                                        
98: R82         Retirement Benefits (Reconciliation Of The Benefit  HTML     66K 
                Obligation) (Details)                                            
99: R83         Retirement Benefits (Changes In Fair Value Of Plan  HTML     63K 
                Assets) (Details)                                                
100: R84         Retirement Benefits (Net Amount Included In         HTML     58K  
                Consolidated Balance Sheets) (Details)                           
101: R85         Retirement Benefits (Net Amounts Included In        HTML     53K  
                Accumulated Other Comprehensive Loss That Have Not               
                Been Recognized As Components Of Net Periodic                    
                Benefit Costs) (Details)                                         
102: R86         Retirement Benefits (Weighted-Average Assumptions   HTML     55K  
                Used In Calculating The Benefit Obligations For                  
                All Plans) (Details)                                             
103: R87         Retirement Benefits (Components Of Net Periodic     HTML     71K  
                Benefit Cost (Benefit Credit) (Details)                          
104: R88         Retirement Benefits (Weighted-Average Assumptions   HTML     56K  
                Used In Calculating Net Periodic Benefit Cost For                
                All Plans) (Details)                                             
105: R89         Retirement Benefits (Fair Values Of Pension         HTML    184K  
                Benefit Assets And Other Benefit Assets By Asset                 
                Category And Level Inputs) (Details)                             
106: R90         Retirement Benefits (Reconciliation Of The          HTML     61K  
                Beginning And Ending Balances Of Plan Assets                     
                Measured At Fair Value Using Level III Inputs)                   
                (Details)                                                        
107: R91         Retirement Benefits (Estimated Future Payments For  HTML     58K  
                Pension Benefits And Other Benefits) (Details)                   
108: R92         Retirement Benefits (Narrative) (Details)           HTML     93K  
109: R93         Medical Claims Payable (Reconciliation Of The       HTML     88K  
                Beginning And Ending Balances For Medical Claims                 
                Payable) (Details)                                               
110: R94         Medical Claims Payable ((Favorable) Unfavorable     HTML     46K  
                Developments By Changes In Key Assumptions)                      
                (Details)                                                        
111: R95         Medical Claims Payable (Reconciliation of Net       HTML     54K  
                Incurred Medical Claims to Benefit Expense)                      
                (Details)                                                        
112: R96         Medical Claims Payable (Incurred and Paid Claims    HTML     74K  
                Development, Net of Reinsurance) (Details)                       
113: R97         Medical Claims Payable (Reconciliation Of The       HTML     72K  
                Claims Development To The Claims Liability)                      
                (Details)                                                        
114: R98         Medical Claims Payable (Narrative) (Details)        HTML     74K  
115: R99         Debt (Carrying Value Of Long-Term Debt) (Details)   HTML    178K  
116: R100        Debt (Convertible Debenture Terms) (Details)        HTML     51K  
117: R101        Debt (Narrative) (Details)                          HTML    354K  
118: R102        Commitments And Contingencies (Details)             HTML     62K  
119: R103        Capital Stock (Summary Of Stock Option Activity)    HTML     78K  
                (Details)                                                        
120: R104        Capital Stock (Nonvested Restricted Stock Activity  HTML     65K  
                Including Restricted Stock Units) (Details)                      
121: R105        Capital Stock (Weighted-Average Assumptions Used    HTML     50K  
                to Estimate the Fair Value of Options Granted)                   
                (Details)                                                        
122: R106        Capital Stock (Weighted-Average Fair Values)        HTML     45K  
                (Details)                                                        
123: R107        Capital Stock (Cash Dividend Activity) (Details)    HTML     53K  
124: R108        Capital Stock (Share Repurchases) (Details)         HTML     50K  
125: R109        Capital Stock (Narrative) (Details)                 HTML    125K  
126: R110        Accumulated Other Comprehensive Loss                HTML    124K  
                (Reconciliation Of The Components Of Accumulated                 
                Other Comprehensive Loss) (Details)                              
127: R111        Reinsurance (Summary Of Direct, Assumed And Ceded   HTML     55K  
                Premiums Earned) (Details)                                       
128: R112        Reinsurance (Summary Of Net Premiums Earned By      HTML     50K  
                Segment) (Details)                                               
129: R113        Reinsurance (Effect Of Reinsurance On Benefit       HTML     49K  
                Expense) (Details)                                               
130: R114        Leases (Lease and Other Information) (Details)      HTML     70K  
131: R115        Leases Leases (Reconciliation of Future Lease       HTML     60K  
                Payments to Total Lease Liabilities) (Details)                   
132: R116        Leases Leases (Narrative) (Details)                 HTML     46K  
133: R117        Earnings Per Share (Denominator For Basic And       HTML     48K  
                Diluted Earnings Per Share) (Details)                            
134: R118        Earnings Per Share (Narrative) (Details)            HTML     45K  
135: R119        Segment Information (Financial Data By Reportable   HTML     69K  
                Segment) (Details)                                               
136: R120        Segment Information (Major Product Revenues)        HTML     70K  
                (Details)                                                        
137: R121        Segment Information (Reconciliation Of Revenue      HTML     55K  
                From Reportable Segments To The Consolidated                     
                Statements Of Income) (Details)                                  
138: R122        Segment Information (Reconciliation Of Reportable   HTML     61K  
                Segment Operating Gain To Income Before Income                   
                Taxes In The Consolidated Statements Of Income)                  
                (Details)                                                        
139: R123        Segment Information (Narrative) (Details)           HTML     50K  
140: R124        Related Party Transactions (Details)                HTML     44K  
141: R125        Statutory Information (Details)                     HTML     60K  
142: R126        Schedule II-Condensed Financial Information Of      HTML    158K  
                Registrant (Balance Sheets) (Details)                            
143: R127        Schedule II-Condensed Financial Information Of      HTML     64K  
                Registrant (Balance Sheets - Additional                          
                Information) (Details)                                           
144: R128        Schedule II-Condensed Financial Information Of      HTML     87K  
                Registrant (Statements Of Income) (Details)                      
145: R129        Schedule II-Condensed Financial Information of      HTML     78K  
                Registrant (Statement of Comprehensive Income)                   
                (Details)                                                        
146: R130        Schedule II-Condensed Financial Information Of      HTML    117K  
                Registrant (Statement Of Cash Flows) (Details)                   
147: R131        Schedule II-Condensed Financial Information Of      HTML     56K  
                Registrant (Narrative) (Details)                                 
150: XML         IDEA XML File -- Filing Summary                      XML    300K  
148: XML         XBRL Instance -- elv-20221231_htm                    XML   7.67M  
149: EXCEL       IDEA Workbook of Financial Reports                  XLSX    377K  
13: EX-101.CAL  XBRL Calculations -- elv-20221231_cal                XML    260K 
14: EX-101.DEF  XBRL Definitions -- elv-20221231_def                 XML   1.72M 
15: EX-101.LAB  XBRL Labels -- elv-20221231_lab                      XML   3.57M 
16: EX-101.PRE  XBRL Presentations -- elv-20221231_pre               XML   2.37M 
12: EX-101.SCH  XBRL Schema -- elv-20221231                          XSD    348K 
151: JSON        XBRL Instance as JSON Data -- MetaLinks              871±  1.44M  
152: ZIP         XBRL Zipped Folder -- 0001156039-23-000007-xbrl      Zip   1.68M  


‘EX-23’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in the following Registration Statements:

Form S-8 No. 333-84906 and Form S-8 No. 333-129334 pertaining to the Elevance Health 401(k) Plan;
Form S-8 No. 333-156099 pertaining to the Elevance Health Employee Stock Purchase Plan;
Form S-8 No. 333-159830 pertaining to the Elevance Health Incentive Compensation Plan;
Form S-8 No. 333-218190 pertaining to the 2017 Elevance Health Incentive Compensation Plan; and
Form S-3 No. 333-249877 pertaining to the Elevance Health, Inc. registration of senior debt securities, subordinated debt securities, preferred stock, common stock, depositary shares, warrants, rights, stock purchase contracts and stock purchase units

of our reports dated February 15, 2023, with respect to the consolidated financial statements and financial statement schedule listed in the Index at Item 15(c) of Elevance Health, Inc., and the effectiveness of internal control over financial reporting of Elevance Health, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2022.

/S/ Ernst & Young LLP

Indianapolis, Indiana
February 15, 2023

1

Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/15/23None on these Dates
For Period end:12/31/22
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/24  Elevance Health, Inc.             S-8         2/23/24    5:450K                                   Donnelley … Solutions/FA
 2/21/24  Elevance Health, Inc.             10-K       12/31/23  153:25M
11/01/23  Elevance Health, Inc.             S-3ASR     11/01/23    6:678K                                   Workiva Inc Wde… FA01/FA


29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/08/23  Elevance Health, Inc.             8-K:8,9     1/30/23   16:619K                                   Donnelley … Solutions/FA
11/04/22  Elevance Health, Inc.             8-K:8,9    10/26/22   16:608K                                   Donnelley … Solutions/FA
 7/20/22  Elevance Health, Inc.             10-Q        6/30/22  105:16M
 6/28/22  Elevance Health, Inc.             8-K:5,9     6/27/22   12:430K                                   Donnelley … Solutions/FA
 4/29/22  Elevance Health, Inc.             8-K:8,9     4/26/22   15:532K                                   Donnelley … Solutions/FA
 4/21/21  Elevance Health, Inc.             10-Q        3/31/21   97:12M
 3/17/21  Elevance Health, Inc.             8-K:8,9     3/08/21   17:677K                                   Donnelley … Solutions/FA
 5/05/20  Elevance Health, Inc.             8-K:8,9     4/30/20   15:550K                                   Donnelley … Solutions/FA
 4/29/20  Elevance Health, Inc.             10-Q        3/31/20   98:13M
 9/09/19  Elevance Health, Inc.             8-K:8,9     9/04/19   16:590K                                   Donnelley … Solutions/FA
 4/24/19  Elevance Health, Inc.             10-Q        3/31/19   95:11M
 7/25/18  Elevance Health, Inc.             10-Q        6/30/18   98:14M
 4/25/18  Elevance Health, Inc.             10-Q        3/31/18   98:12M
 3/02/18  Elevance Health, Inc.             8-K:8,9     2/27/18    6:380K                                   Donnelley … Solutions/FA
11/21/17  Elevance Health, Inc.             8-K:8,9    11/14/17   13:914K                                   Donnelley … Solutions/FA
11/06/17  Elevance Health, Inc.             8-K:5,7,9  11/05/17    4:197K                                   Donnelley … Solutions/FA
 4/27/16  Elevance Health, Inc.             10-Q        3/31/16   94:11M
 5/12/15  Elevance Health, Inc.             8-K:8,9     5/06/15    7:1.8M                                   Donnelley … Solutions/FA
 4/29/15  Elevance Health, Inc.             10-Q        3/31/15   78:13M
 8/12/14  Elevance Health, Inc.             8-K:7,8,9   8/07/14    9:425K                                   Donnelley … Solutions/FA
 7/31/13  Elevance Health, Inc.             8-K:8,9     7/30/13    8:386K                                   Donnelley … Solutions/FA
10/09/12  Elevance Health, Inc.             8-K:2,3,8,910/09/12    2:780K                                   Donnelley … Solutions/FA
 9/10/12  Elevance Health, Inc.             8-K:8,9     9/05/12    9:513K                                   Donnelley … Solutions/FA
 5/07/12  Elevance Health, Inc.             8-K:2,8,9   5/02/12    7:378K                                   Donnelley … Solutions/FA
 8/12/10  Elevance Health, Inc.             8-K:2,8,9   8/09/10    5:344K                                   Donnelley … Solutions/FA
10/24/07  Elevance Health, Inc.             10-Q        9/30/07    6:998K                                   Donnelley … Solutions/FA
 6/08/07  Elevance Health, Inc.             8-K:2,9     6/08/07    4:349K                                   Donnelley … Solutions/FA
 1/11/06  Elevance Health, Inc.             8-K:2,9     1/10/06    6:791K                                   Donnelley … Solutions/FA
12/15/04  Elevance Health, Inc.             8-K:2,9    12/09/04    3:684K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001156039-23-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 5:55:05.1am ET